Crescent Capital BDC (CCAP) Reports $0.37 Q3 Investment Income Per Share

Crescent Capital BDC (CCAP) reported Q3 2026 net investment income of $0.37 per share, net income of $0.27 per share, and NAV of $17.72 per share. The company declared a $0.34 dividend for Q4 and authorized $50M in share repurchases.

Original reporting
Published Nov 9, 2026, 9:15 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 9, 2026, 9:19 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Crescent Capital BDC (CCAP) Reports $0.37 Q3 Investment Income Per Share — source image
Decision brief

The 30-second read

$CCAPBullishMed
01

Why it matters

For BDCs, NAV and NII are key valuation drivers; the dividend and buyback authorization can affect near-term total-return expectations, but the market will ultimately validate sustainability via the forthcoming detailed filing.

02

Market read

This is a company-specific quarterly disclosure with explicit capital-return actions, which can drive trading in income and NAV-sensitive BDC names.

03

What to watch

Traders will likely discount the update until the full quarterly filing clarifies portfolio composition, unrealized losses/gains, and whether NII sustainability supports the dividend.

Relevance 8/10Novelty 7/10Timing: after-hours/late-day publication of Q3 results and capital-return details

Background

The piece summarizes Crescent Capital BDC’s Q3 2026 results, including net investment income, net income, NAV, a declared dividend, and a repurchase authorization.

Company-level read

Ticker impact

$CCAPBullishMedium confidence
Context

Crescent Capital BDC reported Q3 2026 net investment income of $0.37/share, NAV of $17.72/share, and declared a $0.34 dividend plus $50M buyback authorization.

Expected impact

Likely modest support as the market prices in the dividend and capital return, with direction dependent on whether NAV trends and portfolio credit quality match expectations.

Evidence & confidence

The article provides hard quarterly figures (NII, net income, NAV) and explicit capital-return actions (dividend and up to $50M repurchases), which are direct inputs to BDC valuation and income expectations.

Market effects

BDC sector read-through via capital-return signals and NAV trajectory, potentially influencing sentiment toward leveraged income vehicles.

primarily US-listed income/BDC complex sentiment; limited direct regional spillover.

limited, as the disclosure is company-specific and not a macro or cross-border policy event.

Counterpoint

Buyback authorization does not guarantee execution size or timing, so the stock may still trade mainly on NAV/credit quality rather than the headline dividend.

Key entities

  • Crescent Capital BDC, Inc.

    BDC issuer reporting Q3 2026 investment income, NAV, dividend declaration, and up to $50M repurchase authorization.

Related articles

$CCAPHigh

Crescent Capital Q3 2026 slides: earnings beat, $50M buyback unveiled

Crescent Capital BDC (CCAP) reported Q3 2026 earnings of $0.37 per share, beating estimates. The company announced a $50M share buyback and a joint venture to reduce leverage. Shares rose 6.82% in after-hours trading to $9.87, still below NAV. Portfolio assets reached $1.6B, with 91% in senior secured positions. Net investment income declined year-over-year, and NAV per share fell 8%.

$CCAPMed

Crescent Capital BDC, Inc. Reports Third Quarter 2026 Earnings Results

Crescent Capital BDC, Inc. (CCAP) filed an SEC Form 8-K — Results of Operations and Financial Condition. Crescent Capital BDC, Inc. Reports Third Quarter 2026 Earnings Results; Declares a Fourth Quarter Base Dividend of $0.34 Per Share and Announces a $50 Million Share Repurchase Program LOS ANGELES, November 9, 2026 — Crescent Capital BDC, Inc. (“Crescent BDC” or “Company”) (NASDAQ

$CCAPMed

Crescent Capital BDC, Inc. Reports Second Quarter 2026 Earnings Results

Crescent Capital BDC, Inc. (CCAP) filed an SEC Form 8-K — Results of Operations and Financial Condition. Crescent Capital BDC, Inc. Reports Second Quarter 2026 Earnings Results; Declares a Third Quarter Base Dividend of $0.34 Per Share LOS ANGELES, August 10, 2026 — Crescent Capital BDC, Inc. (“Crescent BDC” or “Company”) (NASDAQ: CCAP) today reported net investment income of $0.36

$HIMSMedAI 8/10

Hims & Hers Celebrated Its Eli Lilly Deal, Then Lost a Quarter of Its Value in a Week

Hims & Hers (HIMS) shares fell 25.67% last week, despite a deal with Eli Lilly (LLY) announced on November 6. HIMS reported Q3 revenue of $890.37M, up 48.65%, but margins dropped to 57% from 74%. Lilly's Q3 revenue rose 38.61% to $24.397B, and it raised its full-year outlook to $91B-$92B. HIMS's subscriber base shrank by 100,000 to 2.8M, and it cut full-year Adjusted EBITDA guidance to $257M-$277M.

$ACHRMedAI 8/10

ACHR Stock In Spotlight After Price Target Cuts – Analysts Weigh FAA Progress, Acquisition-Related Revenue Recognition

Archer Aviation (ACHR) saw its price targets lowered by Needham and Cantor Fitzgerald following Q3 results. Needham cut its target to $7 from $9, citing FAA progress and higher cash needs, while Cantor reduced its target to $10 from $11. ACHR reported Q3 revenue of $5.1M, beating estimates, but net loss widened to $274.6M. Seven of nine analysts rate the stock 'Buy' or 'Strong Buy'. ACHR shares traded 5% lower.

$TSMHighAI 8/10

TSMC Stocks Rise 1.64% After October Sales Jump 59.7% to a Record

Taiwan Semiconductor Manufacturing (TSM) shares rose 1.64% to $395.00 after reporting record October revenue of NT$586.89 billion, up 59.7% year-over-year. Sales increased 14.7% from September. January-to-October revenue reached NT$4.486 trillion, up 43.3% year-over-year. GuruFocus rates TSM highly but notes it is fairly valued at current levels.